XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statement Of Changes In Stockholders' Equity (Unaudited) - USD ($)
Total
Revision of Prior Period, Error Correction, Adjustment
Private Warrant
Pre-Funded Warrants
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Revision of Prior Period, Error Correction, Adjustment
Additional Paid-In Capital
Private Warrant
Additional Paid-In Capital
Pre-Funded Warrants
Accumulated Deficit
Series A Preferred
Preferred Stock
Series B Preferred
Preferred Stock
Series C Preferred
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2023         47,672,427           5,875,000 0 770,000
Beginning balance at Dec. 31, 2023 $ 12,948,689       $ 4,767 $ 56,926,161       $ (43,982,904) $ 588 $ 0 $ 77
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 1,657,822         1,657,822              
Stock issued during period, shares, new issues (in shares)         5,357,487                
Shares issued to institutional investor 755,767       $ 536 755,231              
Warrants issues (in shares)     $ 1,081,471 $ 525,905       $ 1,081,471 $ 525,905        
Net income (loss) for the period (4,141,541)                 (4,141,541)      
Ending balance (in shares) at Mar. 31, 2024         53,029,914           5,875,000 0 770,000
Ending balance at Mar. 31, 2024 12,828,113       $ 5,303 60,946,590       (48,124,445) $ 588 $ 0 $ 77
Beginning balance (in shares) at Dec. 31, 2023         47,672,427           5,875,000 0 770,000
Beginning balance at Dec. 31, 2023 12,948,689       $ 4,767 56,926,161       (43,982,904) $ 588 $ 0 $ 77
Ending balance (in shares) at Dec. 31, 2024         77,076,129           5,875,000 0 770,000
Ending balance at Dec. 31, 2024 20,182,026       $ 7,707 74,256,138       (54,082,484) $ 588 $ 0 $ 77
Beginning balance (in shares) at Mar. 31, 2024         53,029,914           5,875,000 0 770,000
Beginning balance at Mar. 31, 2024 12,828,113       $ 5,303 60,946,590       (48,124,445) $ 588 $ 0 $ 77
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 1,127,762         1,127,762              
Net income (loss) for the period (1,876,554)                 (1,876,554)      
Ending balance (in shares) at Jun. 30, 2024         53,029,914           5,875,000 0 770,000
Ending balance at Jun. 30, 2024 12,079,321       $ 5,303 62,074,352       (50,000,999) $ 588 $ 0 $ 77
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 1,252,574         1,252,574              
Stock issued during period, shares, new issues (in shares)         3,080,014                
Shares issued to institutional investor 3,080       $ 308 2,772              
Net income (loss) for the period (1,309,911)                 (1,309,911)      
Ending balance (in shares) at Sep. 30, 2024         56,109,928           5,875,000 0 770,000
Ending balance at Sep. 30, 2024 12,025,064       $ 5,611 63,329,698       (51,310,910) $ 588 $ 0 $ 77
Beginning balance (in shares) at Dec. 31, 2024         77,076,129           5,875,000 0 770,000
Beginning balance at Dec. 31, 2024 20,182,026       $ 7,707 74,256,138       (54,082,484) $ 588 $ 0 $ 77
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 1,179,207         1,179,207              
Shares issued in exercise of stock options (in shares)         110,028                
Stock options exercised 0       $ 11 (11)              
Sale of common stock, net of filing fees (in shares)         4,500,000                
Sale of common stock, net of filing fees 3,995,928       $ 450 3,995,478              
Warrants exercised (in shares)         4,225,717                
Warrants exercised 1,936,601       $ 423 1,936,178              
Preferred stock conversion to common stock (in shares)         125,000               (200,000)
Preferred stock conversion to common stock 1       $ 13 8             $ (20)
Net income (loss) for the period (1,197,031)                 (1,197,031)      
Ending balance (in shares) at Mar. 31, 2025         86,036,874           5,875,000 0 570,000
Ending balance at Mar. 31, 2025 26,096,732       $ 8,604 81,366,998       (55,279,515) $ 588 $ 0 $ 57
Beginning balance (in shares) at Dec. 31, 2024         77,076,129           5,875,000 0 770,000
Beginning balance at Dec. 31, 2024 $ 20,182,026       $ 7,707 74,256,138       (54,082,484) $ 588 $ 0 $ 77
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock issued during period, shares, new issues (in shares)         17,536,621                
Shares issued in exercise of stock options (in shares) 250,000                        
Ending balance (in shares) at Sep. 30, 2025         94,612,750           5,875,000 0 570,000
Ending balance at Sep. 30, 2025 $ 36,728,812       $ 9,461 91,958,566 $ 274,500     (55,239,860) $ 588 $ 0 $ 57
Beginning balance (in shares) at Mar. 31, 2025         86,036,874           5,875,000 0 570,000
Beginning balance at Mar. 31, 2025 26,096,732       $ 8,604 81,366,998       (55,279,515) $ 588 $ 0 $ 57
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 640,021         640,021              
Sale of common stock, net of filing fees (in shares)         4,166,667                
Sale of common stock, net of filing fees 4,470,406       $ 416 4,469,990              
Warrants exercised (in shares)         610,543                
Warrants exercised 639,770       $ 61 639,709              
Balance sheet reclassification adjustment   $ 274,500         274,500            
Net income (loss) for the period (348,927)                 (348,927)      
Ending balance (in shares) at Jun. 30, 2025         90,814,084           5,875,000 0 570,000
Ending balance at Jun. 30, 2025 31,772,502       $ 9,081 87,391,218       (55,628,442) $ 588 $ 0 $ 57
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 284,116         284,116              
Shares issued in exercise of stock options (in shares)         125,000                
Stock options exercised 26,501       $ 13 26,488              
Warrants exercised (in shares)         3,673,666                
Warrants exercised 4,257,111       $ 367 4,256,744              
Net income (loss) for the period 388,582                 388,582      
Ending balance (in shares) at Sep. 30, 2025         94,612,750           5,875,000 0 570,000
Ending balance at Sep. 30, 2025 $ 36,728,812       $ 9,461 $ 91,958,566 $ 274,500     $ (55,239,860) $ 588 $ 0 $ 57